ZAS Corporation Successfully Launches Celltrion Biosimilars in Bangladesh
We are proud to announce the successful launch of Celltrion’s biosimilar products in Bangladesh, marking a significant milestone in our commitment to advancing healthcare in the nation. This launch represents not just the introduction of new treatments but the beginning of a new era in patient care, driven by innovation and quality. Our launch campaign …
ZAS Corporation Successfully Launches Celltrion Biosimilars in Bangladesh Read More »